Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID‐19

Abstract Aims We aimed to assess whether expression of whole‐blood RNA of sodium proton exchanger 1 (NHE1) and glucose transporter 1 (GLUT1) is associated with COVID‐19 infection and outcome in patients presenting to the emergency department with respiratory infections. Furthermore, we investigated...

Full description

Bibliographic Details
Main Authors: Julian Mustroph, Julian Hupf, Frank Hanses, Katja Evert, Maria J. Baier, Matthias Evert, Christine Meindl, Stefan Wagner, Ute Hubauer, Gabriela Pietrzyk, Simon Leininger, Stephan Staudner, Manuel Vogel, Stefan Wallner, Markus Zimmermann, Samuel Sossalla, Lars S. Maier, Carsten Jungbauer
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.13063
_version_ 1818329931244896256
author Julian Mustroph
Julian Hupf
Frank Hanses
Katja Evert
Maria J. Baier
Matthias Evert
Christine Meindl
Stefan Wagner
Ute Hubauer
Gabriela Pietrzyk
Simon Leininger
Stephan Staudner
Manuel Vogel
Stefan Wallner
Markus Zimmermann
Samuel Sossalla
Lars S. Maier
Carsten Jungbauer
author_facet Julian Mustroph
Julian Hupf
Frank Hanses
Katja Evert
Maria J. Baier
Matthias Evert
Christine Meindl
Stefan Wagner
Ute Hubauer
Gabriela Pietrzyk
Simon Leininger
Stephan Staudner
Manuel Vogel
Stefan Wallner
Markus Zimmermann
Samuel Sossalla
Lars S. Maier
Carsten Jungbauer
author_sort Julian Mustroph
collection DOAJ
description Abstract Aims We aimed to assess whether expression of whole‐blood RNA of sodium proton exchanger 1 (NHE1) and glucose transporter 1 (GLUT1) is associated with COVID‐19 infection and outcome in patients presenting to the emergency department with respiratory infections. Furthermore, we investigated NHE1 and GLUT1 expression in the myocardium of deceased COVID‐19 patients. Methods and results Whole‐blood quantitative assessment of NHE1 and GLUT1 RNA was performed using quantitative PCR in patients with respiratory infection upon first contact in the emergency department and subsequently stratified by SARS‐CoV‐2 infection status. Assessment of NHE1 and GLUT1 RNA using PCR was also performed in left ventricular myocardium of deceased COVID‐19 patients. NHE1 expression is up‐regulated in whole blood of patients with COVID‐19 compared with other respiratory infections at first medical contact in the emergency department (control: 0.0021 ± 0.0002, COVID‐19: 0.0031 ± 0.0003, P = 0.01). The ratio of GLUT1 to NHE1 is significantly decreased in the blood of COVID‐19 patients who are subsequently intubated and/or die (severe disease) compared with patients with moderate disease (moderate disease: 0.497 ± 0.083 vs. severe disease: 0.294 ± 0.0336, P = 0.036). This ratio is even further decreased in the myocardium of patients who deceased from COVID‐19 in comparison with the myocardium of non‐infected donors. Conclusions NHE1 and GLUT1 may be critically involved in the disease progression of SARS‐CoV‐2 infection. We show here that SARS‐CoV‐2 infection critically disturbs ion channel expression in the heart. A decreased ratio of GLUT1/NHE1 could potentially serve as a biomarker for disease severity in patients with COVID‐19.
first_indexed 2024-12-13T12:55:54Z
format Article
id doaj.art-755dac0791aa4cb894fc8e6b52253364
institution Directory Open Access Journal
issn 2055-5822
language English
last_indexed 2024-12-13T12:55:54Z
publishDate 2021-02-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj.art-755dac0791aa4cb894fc8e6b522533642022-12-21T23:45:11ZengWileyESC Heart Failure2055-58222021-02-018130931610.1002/ehf2.13063Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID‐19Julian Mustroph0Julian Hupf1Frank Hanses2Katja Evert3Maria J. Baier4Matthias Evert5Christine Meindl6Stefan Wagner7Ute Hubauer8Gabriela Pietrzyk9Simon Leininger10Stephan Staudner11Manuel Vogel12Stefan Wallner13Markus Zimmermann14Samuel Sossalla15Lars S. Maier16Carsten Jungbauer17Department of Internal Medicine II (Cardiology) University Hospital Regensburg Franz‐Josef‐Strauß‐Allee 11 Regensburg 93053 GermanyEmergency Department University Hospital Regensburg Regensburg GermanyEmergency Department University Hospital Regensburg Regensburg GermanyInstitute of Pathology University Hospital Regensburg Regensburg GermanyDepartment of Internal Medicine II (Cardiology) University Hospital Regensburg Franz‐Josef‐Strauß‐Allee 11 Regensburg 93053 GermanyInstitute of Pathology University Hospital Regensburg Regensburg GermanyDepartment of Internal Medicine II (Cardiology) University Hospital Regensburg Franz‐Josef‐Strauß‐Allee 11 Regensburg 93053 GermanyDepartment of Internal Medicine II (Cardiology) University Hospital Regensburg Franz‐Josef‐Strauß‐Allee 11 Regensburg 93053 GermanyDepartment of Internal Medicine II (Cardiology) University Hospital Regensburg Franz‐Josef‐Strauß‐Allee 11 Regensburg 93053 GermanyDepartment of Internal Medicine II (Cardiology) University Hospital Regensburg Franz‐Josef‐Strauß‐Allee 11 Regensburg 93053 GermanyDepartment of Internal Medicine II (Cardiology) University Hospital Regensburg Franz‐Josef‐Strauß‐Allee 11 Regensburg 93053 GermanyDepartment of Internal Medicine II (Cardiology) University Hospital Regensburg Franz‐Josef‐Strauß‐Allee 11 Regensburg 93053 GermanyDepartment of Internal Medicine II (Cardiology) University Hospital Regensburg Franz‐Josef‐Strauß‐Allee 11 Regensburg 93053 GermanyDepartment of Clinical Chemistry and Laboratory Medicine University Hospital Regensburg Regensburg GermanyEmergency Department University Hospital Regensburg Regensburg GermanyDepartment of Internal Medicine II (Cardiology) University Hospital Regensburg Franz‐Josef‐Strauß‐Allee 11 Regensburg 93053 GermanyDepartment of Internal Medicine II (Cardiology) University Hospital Regensburg Franz‐Josef‐Strauß‐Allee 11 Regensburg 93053 GermanyDepartment of Internal Medicine II (Cardiology) University Hospital Regensburg Franz‐Josef‐Strauß‐Allee 11 Regensburg 93053 GermanyAbstract Aims We aimed to assess whether expression of whole‐blood RNA of sodium proton exchanger 1 (NHE1) and glucose transporter 1 (GLUT1) is associated with COVID‐19 infection and outcome in patients presenting to the emergency department with respiratory infections. Furthermore, we investigated NHE1 and GLUT1 expression in the myocardium of deceased COVID‐19 patients. Methods and results Whole‐blood quantitative assessment of NHE1 and GLUT1 RNA was performed using quantitative PCR in patients with respiratory infection upon first contact in the emergency department and subsequently stratified by SARS‐CoV‐2 infection status. Assessment of NHE1 and GLUT1 RNA using PCR was also performed in left ventricular myocardium of deceased COVID‐19 patients. NHE1 expression is up‐regulated in whole blood of patients with COVID‐19 compared with other respiratory infections at first medical contact in the emergency department (control: 0.0021 ± 0.0002, COVID‐19: 0.0031 ± 0.0003, P = 0.01). The ratio of GLUT1 to NHE1 is significantly decreased in the blood of COVID‐19 patients who are subsequently intubated and/or die (severe disease) compared with patients with moderate disease (moderate disease: 0.497 ± 0.083 vs. severe disease: 0.294 ± 0.0336, P = 0.036). This ratio is even further decreased in the myocardium of patients who deceased from COVID‐19 in comparison with the myocardium of non‐infected donors. Conclusions NHE1 and GLUT1 may be critically involved in the disease progression of SARS‐CoV‐2 infection. We show here that SARS‐CoV‐2 infection critically disturbs ion channel expression in the heart. A decreased ratio of GLUT1/NHE1 could potentially serve as a biomarker for disease severity in patients with COVID‐19.https://doi.org/10.1002/ehf2.13063COVID‐19InfectionHeartGLUT1NHE1
spellingShingle Julian Mustroph
Julian Hupf
Frank Hanses
Katja Evert
Maria J. Baier
Matthias Evert
Christine Meindl
Stefan Wagner
Ute Hubauer
Gabriela Pietrzyk
Simon Leininger
Stephan Staudner
Manuel Vogel
Stefan Wallner
Markus Zimmermann
Samuel Sossalla
Lars S. Maier
Carsten Jungbauer
Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID‐19
ESC Heart Failure
COVID‐19
Infection
Heart
GLUT1
NHE1
title Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID‐19
title_full Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID‐19
title_fullStr Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID‐19
title_full_unstemmed Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID‐19
title_short Decreased GLUT1/NHE1 RNA expression in whole blood predicts disease severity in patients with COVID‐19
title_sort decreased glut1 nhe1 rna expression in whole blood predicts disease severity in patients with covid 19
topic COVID‐19
Infection
Heart
GLUT1
NHE1
url https://doi.org/10.1002/ehf2.13063
work_keys_str_mv AT julianmustroph decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT julianhupf decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT frankhanses decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT katjaevert decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT mariajbaier decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT matthiasevert decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT christinemeindl decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT stefanwagner decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT utehubauer decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT gabrielapietrzyk decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT simonleininger decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT stephanstaudner decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT manuelvogel decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT stefanwallner decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT markuszimmermann decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT samuelsossalla decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT larssmaier decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19
AT carstenjungbauer decreasedglut1nhe1rnaexpressioninwholebloodpredictsdiseaseseverityinpatientswithcovid19